| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Monitoring | 23 | 2013 | 56 | 2.770 |
Why?
|
| Oximetry | 18 | 2011 | 172 | 2.110 |
Why?
|
| Postpartum Hemorrhage | 9 | 2021 | 98 | 1.790 |
Why?
|
| Embolism, Amniotic Fluid | 6 | 2021 | 31 | 1.670 |
Why?
|
| Pregnancy | 105 | 2021 | 7258 | 1.620 |
Why?
|
| Pregnancy Complications | 13 | 2018 | 517 | 1.330 |
Why?
|
| Obstetrics | 8 | 2017 | 238 | 1.290 |
Why?
|
| Maternal Mortality | 7 | 2018 | 80 | 1.270 |
Why?
|
| Oxygen | 12 | 2011 | 560 | 1.150 |
Why?
|
| Pre-Eclampsia | 7 | 2017 | 223 | 1.090 |
Why?
|
| Delivery, Obstetric | 12 | 2017 | 251 | 0.970 |
Why?
|
| Cesarean Section | 16 | 2021 | 393 | 0.960 |
Why?
|
| Obstetric Labor Complications | 6 | 2018 | 93 | 0.950 |
Why?
|
| Fetal Blood | 13 | 2001 | 175 | 0.880 |
Why?
|
| Gynecology | 4 | 2017 | 124 | 0.790 |
Why?
|
| Heart Rate, Fetal | 9 | 2013 | 63 | 0.740 |
Why?
|
| Fetal Hypoxia | 5 | 2011 | 14 | 0.720 |
Why?
|
| Checklist | 1 | 2021 | 86 | 0.670 |
Why?
|
| Amniotic Fluid | 9 | 2004 | 150 | 0.650 |
Why?
|
| Female | 112 | 2021 | 67337 | 0.640 |
Why?
|
| Obstetric Labor, Premature | 7 | 2008 | 85 | 0.630 |
Why?
|
| Maternal Death | 1 | 2018 | 9 | 0.590 |
Why?
|
| Pregnancy Outcome | 14 | 2017 | 599 | 0.580 |
Why?
|
| Simulation Training | 2 | 2018 | 140 | 0.570 |
Why?
|
| Ultrasonography, Prenatal | 15 | 2013 | 974 | 0.560 |
Why?
|
| Dystocia | 6 | 2008 | 24 | 0.540 |
Why?
|
| Obstetrical Forceps | 1 | 2016 | 8 | 0.530 |
Why?
|
| Extraction, Obstetrical | 1 | 2016 | 9 | 0.530 |
Why?
|
| Labor, Obstetric | 8 | 2013 | 94 | 0.520 |
Why?
|
| Uterine Balloon Tamponade | 2 | 2013 | 6 | 0.520 |
Why?
|
| Humans | 116 | 2021 | 126366 | 0.470 |
Why?
|
| Reproduction | 1 | 2017 | 239 | 0.460 |
Why?
|
| Intensive Care Units | 1 | 2018 | 502 | 0.450 |
Why?
|
| Hysterectomy | 5 | 2019 | 187 | 0.450 |
Why?
|
| Ethics, Medical | 3 | 2017 | 398 | 0.440 |
Why?
|
| Placenta Accreta | 4 | 2019 | 161 | 0.420 |
Why?
|
| Specialization | 1 | 2013 | 77 | 0.400 |
Why?
|
| Placenta Diseases | 4 | 2018 | 59 | 0.400 |
Why?
|
| Critical Care | 1 | 2018 | 662 | 0.400 |
Why?
|
| Pregnancy, High-Risk | 6 | 2006 | 43 | 0.380 |
Why?
|
| Decision Making | 1 | 2017 | 671 | 0.370 |
Why?
|
| Acidosis | 2 | 2011 | 98 | 0.360 |
Why?
|
| Uterine Hemorrhage | 3 | 2008 | 43 | 0.360 |
Why?
|
| Adult | 53 | 2018 | 29800 | 0.350 |
Why?
|
| Cervix Uteri | 6 | 2008 | 63 | 0.350 |
Why?
|
| Maternal Age | 5 | 2017 | 135 | 0.340 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 525 | 0.330 |
Why?
|
| Curriculum | 1 | 2015 | 735 | 0.320 |
Why?
|
| Parity | 6 | 2017 | 78 | 0.320 |
Why?
|
| Eikenella corrodens | 1 | 2008 | 4 | 0.310 |
Why?
|
| Body Piercing | 1 | 2008 | 4 | 0.310 |
Why?
|
| Chorioamnionitis | 2 | 2008 | 43 | 0.310 |
Why?
|
| Magnesium Sulfate | 2 | 2008 | 49 | 0.300 |
Why?
|
| Internship and Residency | 2 | 2017 | 1189 | 0.300 |
Why?
|
| Cerebrovascular Circulation | 3 | 2008 | 464 | 0.290 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 84 | 0.290 |
Why?
|
| Blood Pressure | 6 | 2018 | 1357 | 0.290 |
Why?
|
| Fetus | 5 | 2008 | 590 | 0.290 |
Why?
|
| Reproductive Techniques, Assisted | 3 | 2017 | 73 | 0.290 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 1995 | 105 | 0.290 |
Why?
|
| Uterine Inertia | 2 | 2021 | 4 | 0.290 |
Why?
|
| Shock | 2 | 2020 | 91 | 0.290 |
Why?
|
| Bandages | 2 | 2006 | 59 | 0.280 |
Why?
|
| Parturition | 1 | 2008 | 64 | 0.280 |
Why?
|
| Hemostatic Techniques | 1 | 2006 | 32 | 0.260 |
Why?
|
| Blood Gas Analysis | 3 | 2007 | 86 | 0.260 |
Why?
|
| Birth Rate | 2 | 2016 | 17 | 0.240 |
Why?
|
| Pregnancy Trimester, Second | 13 | 2010 | 167 | 0.240 |
Why?
|
| Patient Care Team | 3 | 2018 | 551 | 0.240 |
Why?
|
| Polyhydramnios | 2 | 2004 | 56 | 0.240 |
Why?
|
| Birth Injuries | 2 | 2006 | 22 | 0.230 |
Why?
|
| Myasthenia Gravis | 1 | 2005 | 74 | 0.230 |
Why?
|
| Meningoencephalitis | 1 | 2004 | 18 | 0.220 |
Why?
|
| Stillbirth | 2 | 2018 | 80 | 0.220 |
Why?
|
| Prenatal Care | 1 | 2007 | 349 | 0.220 |
Why?
|
| Collagenases | 1 | 2004 | 18 | 0.220 |
Why?
|
| Heart Arrest | 2 | 2021 | 359 | 0.210 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 465 | 0.210 |
Why?
|
| Lymphangioma, Cystic | 1 | 2003 | 16 | 0.210 |
Why?
|
| Infant, Newborn | 17 | 2017 | 8301 | 0.210 |
Why?
|
| United States | 17 | 2020 | 10994 | 0.200 |
Why?
|
| Physician's Role | 2 | 2015 | 171 | 0.200 |
Why?
|
| Risk Factors | 13 | 2020 | 10377 | 0.200 |
Why?
|
| Chylothorax | 1 | 2003 | 29 | 0.200 |
Why?
|
| Premature Birth | 3 | 2017 | 391 | 0.200 |
Why?
|
| Seizures | 1 | 2008 | 871 | 0.200 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2017 | 740 | 0.190 |
Why?
|
| West Nile Fever | 1 | 2004 | 139 | 0.190 |
Why?
|
| Acid-Base Equilibrium | 2 | 1999 | 60 | 0.190 |
Why?
|
| Fetal Death | 3 | 2018 | 113 | 0.190 |
Why?
|
| Emergency Treatment | 1 | 2002 | 84 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2004 | 473 | 0.180 |
Why?
|
| Airway Obstruction | 1 | 2003 | 166 | 0.180 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 2934 | 0.170 |
Why?
|
| Fetal Diseases | 7 | 2003 | 458 | 0.170 |
Why?
|
| Prenatal Diagnosis | 6 | 2010 | 607 | 0.170 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2021 | 68 | 0.170 |
Why?
|
| Shoulder Injuries | 1 | 2000 | 6 | 0.170 |
Why?
|
| Education, Medical | 1 | 2004 | 290 | 0.170 |
Why?
|
| Shoulder Dislocation | 1 | 2000 | 8 | 0.170 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 1992 | 63 | 0.170 |
Why?
|
| Airway Management | 1 | 2021 | 63 | 0.170 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2021 | 76 | 0.170 |
Why?
|
| Perineum | 2 | 2017 | 47 | 0.160 |
Why?
|
| Registries | 4 | 2020 | 1453 | 0.150 |
Why?
|
| Gestational Age | 10 | 2017 | 1174 | 0.150 |
Why?
|
| Placenta Previa | 1 | 2019 | 66 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 1 | 2003 | 504 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 442 | 0.140 |
Why?
|
| Fetal Heart | 2 | 1996 | 120 | 0.140 |
Why?
|
| Circumcision, Female | 1 | 2017 | 5 | 0.140 |
Why?
|
| Placentation | 2 | 2019 | 55 | 0.140 |
Why?
|
| Hymen | 1 | 2017 | 12 | 0.140 |
Why?
|
| Hospital Rapid Response Team | 1 | 2018 | 36 | 0.140 |
Why?
|
| Fetal Mortality | 1 | 2017 | 7 | 0.140 |
Why?
|
| Pressure | 4 | 2011 | 132 | 0.140 |
Why?
|
| Cultural Characteristics | 1 | 2017 | 41 | 0.140 |
Why?
|
| Episiotomy | 1 | 2017 | 17 | 0.140 |
Why?
|
| Postpartum Period | 4 | 2011 | 216 | 0.140 |
Why?
|
| Patient Transfer | 1 | 2018 | 109 | 0.140 |
Why?
|
| Learning Curve | 1 | 2017 | 53 | 0.140 |
Why?
|
| Postoperative Complications | 3 | 2006 | 3078 | 0.130 |
Why?
|
| Retrospective Studies | 17 | 2019 | 16522 | 0.130 |
Why?
|
| Acid-Base Imbalance | 3 | 2004 | 27 | 0.130 |
Why?
|
| Maternal-Child Health Services | 1 | 2016 | 13 | 0.130 |
Why?
|
| Blood Transfusion | 2 | 2013 | 314 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2013 | 454 | 0.130 |
Why?
|
| Infertility, Female | 1 | 2017 | 144 | 0.130 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1996 | 11 | 0.130 |
Why?
|
| Incidence | 6 | 2020 | 3166 | 0.130 |
Why?
|
| Birth Certificates | 1 | 2016 | 13 | 0.130 |
Why?
|
| Indicator Dilution Techniques | 2 | 1995 | 25 | 0.130 |
Why?
|
| Benchmarking | 1 | 2017 | 139 | 0.130 |
Why?
|
| Sexual Abstinence | 1 | 2015 | 4 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 131 | 0.130 |
Why?
|
| Perinatal Care | 1 | 2016 | 67 | 0.130 |
Why?
|
| Uterus | 2 | 2011 | 568 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 1276 | 0.120 |
Why?
|
| Placenta | 2 | 2013 | 513 | 0.120 |
Why?
|
| Fast Foods | 1 | 2015 | 35 | 0.120 |
Why?
|
| Guideline Adherence | 2 | 2016 | 379 | 0.120 |
Why?
|
| Commerce | 1 | 2015 | 51 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 221 | 0.120 |
Why?
|
| Life Support Care | 1 | 1995 | 48 | 0.120 |
Why?
|
| Predictive Value of Tests | 7 | 2011 | 2195 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2018 | 12386 | 0.110 |
Why?
|
| Food Supply | 1 | 2015 | 101 | 0.110 |
Why?
|
| Reproductive Behavior | 1 | 2014 | 7 | 0.110 |
Why?
|
| Vascular Resistance | 4 | 2001 | 188 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2008 | 458 | 0.110 |
Why?
|
| Research Design | 1 | 2018 | 709 | 0.110 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 267 | 0.110 |
Why?
|
| Young Adult | 6 | 2018 | 9166 | 0.110 |
Why?
|
| Middle Cerebral Artery | 2 | 2008 | 115 | 0.110 |
Why?
|
| Physicians, Women | 1 | 2014 | 48 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 107 | 0.110 |
Why?
|
| Middle Aged | 7 | 2017 | 27046 | 0.110 |
Why?
|
| Patient Safety | 1 | 2018 | 400 | 0.110 |
Why?
|
| Prospective Studies | 9 | 2017 | 6177 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1034 | 0.100 |
Why?
|
| Physical Fitness | 1 | 1993 | 90 | 0.100 |
Why?
|
| Respiration | 1 | 1993 | 122 | 0.100 |
Why?
|
| Blood Volume | 2 | 2008 | 81 | 0.100 |
Why?
|
| Hyperoxia | 1 | 1994 | 130 | 0.100 |
Why?
|
| Patient Selection | 1 | 2016 | 703 | 0.100 |
Why?
|
| Thoracic Surgery | 1 | 2014 | 160 | 0.100 |
Why?
|
| Case-Control Studies | 6 | 2018 | 3343 | 0.100 |
Why?
|
| Indomethacin | 1 | 1992 | 83 | 0.100 |
Why?
|
| Latin America | 1 | 2012 | 93 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 446 | 0.090 |
Why?
|
| Asia | 1 | 2012 | 112 | 0.090 |
Why?
|
| Africa | 1 | 2012 | 133 | 0.090 |
Why?
|
| Hypertension | 3 | 1991 | 1296 | 0.090 |
Why?
|
| Eclampsia | 1 | 1991 | 29 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1113 | 0.090 |
Why?
|
| Medical Audit | 1 | 2012 | 98 | 0.090 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2007 | 92 | 0.090 |
Why?
|
| Leiomyoma | 1 | 1992 | 81 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 2 | 2017 | 130 | 0.090 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 1991 | 37 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2012 | 185 | 0.090 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2008 | 115 | 0.090 |
Why?
|
| Uterine Neoplasms | 1 | 1992 | 106 | 0.090 |
Why?
|
| Uterine Artery | 1 | 2011 | 29 | 0.090 |
Why?
|
| Puerperal Disorders | 2 | 2009 | 45 | 0.090 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 306 | 0.090 |
Why?
|
| Exercise | 2 | 1994 | 828 | 0.090 |
Why?
|
| Cysts | 1 | 1991 | 102 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 211 | 0.090 |
Why?
|
| Vagina | 2 | 2008 | 185 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2016 | 526 | 0.090 |
Why?
|
| Quality of Health Care | 2 | 2017 | 399 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2016 | 653 | 0.090 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2004 | 120 | 0.080 |
Why?
|
| Labor, Induced | 1 | 2010 | 34 | 0.080 |
Why?
|
| Typhoid Fever | 1 | 1990 | 21 | 0.080 |
Why?
|
| Cholecystitis | 1 | 2009 | 20 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2005 | 389 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2010 | 142 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 1008 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 1 | 1989 | 51 | 0.080 |
Why?
|
| Vaginosis, Bacterial | 1 | 2008 | 18 | 0.080 |
Why?
|
| Term Birth | 1 | 2008 | 32 | 0.080 |
Why?
|
| Compensation and Redress | 1 | 2008 | 12 | 0.080 |
Why?
|
| Uterine Rupture | 1 | 2009 | 18 | 0.080 |
Why?
|
| Cerebral Arteries | 2 | 1999 | 82 | 0.080 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2010 | 317 | 0.080 |
Why?
|
| Heart | 1 | 1993 | 736 | 0.070 |
Why?
|
| Recurrence | 3 | 2007 | 1397 | 0.070 |
Why?
|
| Brain Diseases | 1 | 1991 | 301 | 0.070 |
Why?
|
| Malpractice | 1 | 2008 | 54 | 0.070 |
Why?
|
| Appendicitis | 1 | 2009 | 128 | 0.070 |
Why?
|
| Palliative Care | 1 | 1992 | 440 | 0.070 |
Why?
|
| Endosonography | 3 | 2004 | 80 | 0.070 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2008 | 28 | 0.070 |
Why?
|
| Louisiana | 1 | 2008 | 135 | 0.070 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 2071 | 0.070 |
Why?
|
| Fibronectins | 1 | 2008 | 110 | 0.070 |
Why?
|
| Chromosome Disorders | 1 | 2010 | 310 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2008 | 1341 | 0.070 |
Why?
|
| Marijuana Abuse | 1 | 2008 | 49 | 0.070 |
Why?
|
| Uterine Prolapse | 1 | 2007 | 18 | 0.070 |
Why?
|
| Specimen Handling | 1 | 2008 | 142 | 0.070 |
Why?
|
| Prostaglandins | 2 | 2009 | 48 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2008 | 238 | 0.070 |
Why?
|
| Shoulder | 1 | 2006 | 29 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2007 | 81 | 0.070 |
Why?
|
| Urban Population | 1 | 2008 | 230 | 0.060 |
Why?
|
| Coitus | 1 | 2006 | 20 | 0.060 |
Why?
|
| Birth Weight | 3 | 2017 | 346 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 1910 | 0.060 |
Why?
|
| Pneumonia | 1 | 2009 | 328 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2009 | 393 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1838 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 201 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2001 | 845 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2007 | 5202 | 0.060 |
Why?
|
| Infant Mortality | 2 | 2016 | 176 | 0.060 |
Why?
|
| Graves Disease | 1 | 2005 | 15 | 0.060 |
Why?
|
| Exophthalmos | 1 | 2005 | 38 | 0.060 |
Why?
|
| Extraembryonic Membranes | 1 | 2004 | 14 | 0.060 |
Why?
|
| Orbit | 1 | 2005 | 103 | 0.060 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 126 | 0.060 |
Why?
|
| Oligohydramnios | 3 | 1996 | 46 | 0.060 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Age Factors | 2 | 2008 | 2836 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2001 | 1131 | 0.050 |
Why?
|
| Oxytocin | 2 | 2002 | 69 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 1 | 2004 | 115 | 0.050 |
Why?
|
| Male | 8 | 2017 | 62042 | 0.050 |
Why?
|
| Amniocentesis | 1 | 2004 | 77 | 0.050 |
Why?
|
| Vibration | 1 | 2003 | 34 | 0.050 |
Why?
|
| Antihypertensive Agents | 3 | 1991 | 390 | 0.050 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2004 | 60 | 0.050 |
Why?
|
| Heart Rate | 2 | 2018 | 583 | 0.050 |
Why?
|
| Acoustic Stimulation | 1 | 2003 | 86 | 0.050 |
Why?
|
| Forecasting | 2 | 1996 | 358 | 0.050 |
Why?
|
| Fetal Macrosomia | 2 | 2000 | 20 | 0.050 |
Why?
|
| West Nile virus | 1 | 2004 | 117 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 258 | 0.050 |
Why?
|
| Carboprost | 1 | 2002 | 1 | 0.050 |
Why?
|
| Methylergonovine | 1 | 2002 | 1 | 0.050 |
Why?
|
| Ergot Alkaloids | 1 | 2002 | 2 | 0.050 |
Why?
|
| Tromethamine | 1 | 2002 | 9 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 1080 | 0.050 |
Why?
|
| Ultrasonography | 3 | 2007 | 943 | 0.050 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2002 | 33 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2010 | 1020 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2001 | 457 | 0.050 |
Why?
|
| Mass Screening | 1 | 2008 | 787 | 0.050 |
Why?
|
| Hematocrit | 3 | 2008 | 114 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 876 | 0.050 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2003 | 109 | 0.050 |
Why?
|
| Headache | 2 | 1999 | 107 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2003 | 364 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2002 | 77 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 829 | 0.050 |
Why?
|
| Abnormalities, Multiple | 2 | 2010 | 962 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2004 | 324 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 1999 | 144 | 0.050 |
Why?
|
| Echocardiography | 2 | 1997 | 1075 | 0.050 |
Why?
|
| ROC Curve | 2 | 2018 | 577 | 0.050 |
Why?
|
| Adolescent | 6 | 2017 | 19531 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2002 | 267 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 635 | 0.050 |
Why?
|
| Reference Values | 6 | 2001 | 722 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 2 | 2004 | 274 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2007 | 3460 | 0.040 |
Why?
|
| Scalp | 1 | 2001 | 57 | 0.040 |
Why?
|
| Pregnancy in Diabetics | 1 | 2000 | 19 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2001 | 152 | 0.040 |
Why?
|
| Posture | 1 | 2000 | 149 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2002 | 219 | 0.040 |
Why?
|
| Apgar Score | 2 | 1996 | 49 | 0.040 |
Why?
|
| Neck | 1 | 2000 | 135 | 0.040 |
Why?
|
| Retinal Artery | 1 | 1999 | 16 | 0.040 |
Why?
|
| Ophthalmic Artery | 1 | 1999 | 23 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 1989 | 1677 | 0.040 |
Why?
|
| Sex Factors | 2 | 2000 | 1293 | 0.040 |
Why?
|
| Live Birth | 1 | 2018 | 56 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 3456 | 0.040 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1998 | 21 | 0.040 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1998 | 21 | 0.040 |
Why?
|
| Logistic Models | 2 | 2018 | 1812 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 2901 | 0.040 |
Why?
|
| Texas | 2 | 2017 | 3586 | 0.040 |
Why?
|
| Chorionic Gonadotropin | 1 | 1998 | 79 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 193 | 0.030 |
Why?
|
| Pericardial Effusion | 1 | 1997 | 62 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 99 | 0.030 |
Why?
|
| Inservice Training | 1 | 2017 | 56 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 35 | 0.030 |
Why?
|
| Cardiotocography | 1 | 1997 | 20 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1998 | 784 | 0.030 |
Why?
|
| Reproductive Techniques | 1 | 1996 | 8 | 0.030 |
Why?
|
| Sex Ratio | 1 | 1996 | 11 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 1998 | 219 | 0.030 |
Why?
|
| Gravidity | 1 | 2016 | 10 | 0.030 |
Why?
|
| Breech Presentation | 1 | 2016 | 20 | 0.030 |
Why?
|
| Population | 1 | 2016 | 21 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 167 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 1996 | 71 | 0.030 |
Why?
|
| Intensive Care, Neonatal | 1 | 1996 | 54 | 0.030 |
Why?
|
| Umbilical Arteries | 1 | 1996 | 98 | 0.030 |
Why?
|
| Fetal Distress | 2 | 1996 | 12 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 3715 | 0.030 |
Why?
|
| Pregnancy, Multiple | 1 | 1996 | 47 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1998 | 421 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 152 | 0.030 |
Why?
|
| HIV Infections | 1 | 2008 | 1909 | 0.030 |
Why?
|
| Environment Design | 1 | 2015 | 15 | 0.030 |
Why?
|
| Geographic Mapping | 1 | 2015 | 15 | 0.030 |
Why?
|
| Beneficence | 1 | 2015 | 84 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 41 | 0.030 |
Why?
|
| Social Justice | 1 | 2015 | 59 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 2 | 2011 | 194 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 123 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2016 | 177 | 0.030 |
Why?
|
| Pregnancy, Twin | 1 | 2016 | 180 | 0.030 |
Why?
|
| Labor Onset | 1 | 1994 | 4 | 0.030 |
Why?
|
| Personal Autonomy | 1 | 2015 | 202 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 1994 | 58 | 0.030 |
Why?
|
| Linear Models | 3 | 2004 | 694 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1996 | 174 | 0.030 |
Why?
|
| Respiratory Dead Space | 1 | 1993 | 4 | 0.030 |
Why?
|
| Aerobiosis | 1 | 1993 | 13 | 0.030 |
Why?
|
| Heart Block | 1 | 1993 | 41 | 0.030 |
Why?
|
| Norethindrone | 1 | 1993 | 6 | 0.030 |
Why?
|
| Tidal Volume | 1 | 1993 | 41 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 1993 | 33 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 270 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 588 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1993 | 65 | 0.030 |
Why?
|
| Cardiac Output | 1 | 1993 | 170 | 0.030 |
Why?
|
| Utah | 2 | 2006 | 46 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 1993 | 136 | 0.030 |
Why?
|
| Urinary Bladder Fistula | 1 | 1992 | 4 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 1596 | 0.020 |
Why?
|
| Megacolon | 1 | 1992 | 4 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1993 | 134 | 0.020 |
Why?
|
| Rectal Fistula | 1 | 1992 | 4 | 0.020 |
Why?
|
| Proteins | 1 | 1998 | 1045 | 0.020 |
Why?
|
| Exercise Test | 1 | 1993 | 256 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1993 | 280 | 0.020 |
Why?
|
| Urethra | 1 | 1992 | 85 | 0.020 |
Why?
|
| Anal Canal | 1 | 1992 | 80 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1992 | 257 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 1991 | 34 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2017 | 836 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 1991 | 35 | 0.020 |
Why?
|
| Abruptio Placentae | 1 | 1991 | 16 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2010 | 4875 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 1991 | 103 | 0.020 |
Why?
|
| Prognosis | 3 | 2004 | 4734 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 1996 | 399 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1995 | 322 | 0.020 |
Why?
|
| Manometry | 1 | 2011 | 60 | 0.020 |
Why?
|
| Bradycardia | 1 | 1991 | 60 | 0.020 |
Why?
|
| Stroke Volume | 1 | 1993 | 501 | 0.020 |
Why?
|
| DNA | 1 | 1996 | 1623 | 0.020 |
Why?
|
| Length of Stay | 1 | 1996 | 1325 | 0.020 |
Why?
|
| Ovary | 1 | 1993 | 375 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 731 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2005 | 2108 | 0.020 |
Why?
|
| Salmonella typhi | 1 | 1990 | 18 | 0.020 |
Why?
|
| Aspirin | 1 | 1991 | 223 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1991 | 225 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 321 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 427 | 0.020 |
Why?
|
| Misoprostol | 1 | 2009 | 26 | 0.020 |
Why?
|
| Peer Review, Health Care | 1 | 2009 | 17 | 0.020 |
Why?
|
| Algorithms | 2 | 2013 | 1648 | 0.020 |
Why?
|
| Oxytocics | 1 | 2009 | 28 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 1991 | 383 | 0.020 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2008 | 23 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1992 | 331 | 0.020 |
Why?
|
| Lacerations | 1 | 2008 | 33 | 0.020 |
Why?
|
| Medical Records | 1 | 2009 | 192 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 56 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2008 | 161 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 210 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2008 | 271 | 0.020 |
Why?
|
| Animals | 2 | 1999 | 34548 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1991 | 375 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1988 | 240 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 1989 | 711 | 0.020 |
Why?
|
| Cause of Death | 1 | 2008 | 478 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 320 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 378 | 0.020 |
Why?
|
| Vision Tests | 1 | 2005 | 36 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 435 | 0.010 |
Why?
|
| Myometrium | 1 | 2004 | 47 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2005 | 91 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 268 | 0.010 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2004 | 6 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 142 | 0.010 |
Why?
|
| Labor Stage, First | 1 | 2004 | 7 | 0.010 |
Why?
|
| Steroids | 1 | 2005 | 203 | 0.010 |
Why?
|
| Optic Nerve Diseases | 1 | 2005 | 88 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1438 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 1613 | 0.010 |
Why?
|
| Time Factors | 1 | 1992 | 6338 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1304 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1253 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1039 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 12667 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 2000 | 9 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1517 | 0.010 |
Why?
|
| Scotoma | 1 | 1999 | 16 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2003 | 463 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1999 | 57 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 3045 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 2825 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1789 | 0.010 |
Why?
|
| Meconium | 1 | 1996 | 12 | 0.010 |
Why?
|
| Twins | 1 | 1996 | 69 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1996 | 109 | 0.010 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1996 | 98 | 0.010 |
Why?
|
| Neonatal Screening | 1 | 1996 | 187 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1994 | 21 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 1995 | 82 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1997 | 550 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 1996 | 238 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 3623 | 0.010 |
Why?
|
| Luteal Phase | 1 | 1993 | 8 | 0.010 |
Why?
|
| Shock, Septic | 1 | 1995 | 148 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1994 | 124 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1996 | 259 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1993 | 131 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1993 | 117 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1993 | 80 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1995 | 187 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1994 | 315 | 0.010 |
Why?
|
| Traction | 1 | 1991 | 9 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1991 | 51 | 0.010 |
Why?
|
| Estradiol | 1 | 1993 | 528 | 0.010 |
Why?
|
| Progesterone | 1 | 1993 | 621 | 0.010 |
Why?
|
| Survival Rate | 1 | 1995 | 2071 | 0.010 |
Why?
|
| Lincomycin | 1 | 1966 | 2 | 0.000 |
Why?
|
| Biomarkers | 1 | 1996 | 3154 | 0.000 |
Why?
|
| Vaginitis | 1 | 1966 | 5 | 0.000 |
Why?
|
| Cystitis | 1 | 1966 | 43 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1966 | 973 | 0.000 |
Why?
|